Rep. Oliverson calls for transparency in Texas’ 340B program, while oversight concerns continue to grow in Pennsylvania
Rep. Tom Oliverson called for greater transparency in the 340B Drug Pricing Program, raising concerns about its effects on the pharmaceutical supply chain and benefits received by certain pharmacies.









